Furthermore, transwell analysis results displayed that the migration of NSCLC cells elevated by miR‐148b inhibitor was reversed by transfection of miR‐148b inhibitor and ALCAM siRNA (Fig 4c). This evidence concerns the gene ALCAM and non-small cell lung carcinoma.